At 2pm on November 11, 2022, with the sudden appearance of a rainbow in the sky, the world's first 30,000-liter stainless steel mammalian cell bioreactor was unveiled in Lingang, Shanghai. This is the core equipment of BIBO Pharma's large-scale CDMO comprehensive platform project for biopharmaceuticals located in Lingang, Shanghai (referred…

In September 2022, Shanghai TopAlliance Biomedical Technology Co., Ltd. (referred as "TopAlliance") and Shanghai BiBo Biomedical Engineering Co., Ltd. (referred as "BiBo Pharma") signed a strategic cooperation agreement in Shanghai. According to the agreement, the two parties will carry out in-depth cooperation in biotech drug technology development and commercial production based on their…

On October 22, 2022, after nearly 10 months of careful preparation and unremitting efforts, the P02 production site of BiBo Pharma which located in Lingang Blue Bay has successfully completed the EU QP on-site audit. The audit has no serious defects (Critical, 0) and no major defects (Major, 0). The…

On August 18, 2021, the construction of Shanghai BiBo Biopharmaceuticals large-scale CDMO integrated platform phase II (P03) project has been officially started, and held a groundbreaking ceremony in the new Lingang area of China (Shanghai) Pilot Free Trade Zone. This represented the construction of the world's first 30,000-liter large-scale mammalian…

After 147 days of efforts by all staffs of Shanghai BiBo, on May 20, 2021, Shanghai BiBo Biopharmaceuticals large-scale CDMO integrated production platform Lingang Phase I (P02), was officially handed over from BiBo Engineering Department to Manufacture Department, marking the verification and commissioning stage of the very few among the…